Polypeptides and Polynucleotides Encoding Same and Use Thereof in the Treatment of Medical Conditions Associated with Ischemia

Details for Australian Patent Application No. 2012204128 (hide)

Owner Vascular Biogenics Ltd.

Inventors Breitbart, Eyal; Bangio, Livnat; Tal, Reshef

Agent Cullens

Pub. Number AU-A-2012204128

Parent 2007280017

Filing date 12 July 2012

Wipo publication date 2 August 2012

International Classifications

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 38/17 Medicinal preparations containing peptides - from animals

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/47 Peptides having more than 20 amino acids

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

26 July 2012 Complete Application Filed

2 August 2012 Application Open to Public Inspection

  Published as AU-A-2012204128

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012204129-CYPIBI nucleic acids and methods of use

2012204127-Improved overblow cable installation method and apparatus for installing cables in a conduit